Clover Health Investments, Corp. (CLOV) stock
CLOVNasdaqHospital & Medical Service PlansFiscal year ends December 31
$4.88−0.09 (-1.81%)
Close on Nov 12, 2026Market cap $2.59BP/E 488.0Yield –
Clover Health Investments operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Clover Health Investments's operating income for the twelve months ending Sep 30, 2026 was $12.45M. For fiscal 2025 it was -$85.53M. The highest annual figure on record is -$45.75M in fiscal 2024.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$85.53M | – |
| FY2024 | Dec 31, 2024 | -$45.75M | – |
| FY2023 | Dec 31, 2023 | -$205.33M | – |
| FY2022 | Dec 31, 2022 | -$286.66M | – |
| FY2021 | Dec 31, 2021 | -$636.99M | – |
| FY2020 | Dec 31, 2020 | -$92.71M | – |
| FY2019 | Dec 31, 2019 | -$183.20M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $6.44M | – |
| Q2 FY2026 | Jun 30, 2026 | $28.00M | – |
| Q1 FY2026 | Mar 31, 2026 | $27.33M | – |
| Q4 FY2025 | Dec 31, 2025 | -$49.32M | – |
| Q3 FY2025 | Sep 30, 2025 | -$24.38M | – |
| Q2 FY2025 | Jun 30, 2025 | -$10.56M | -246.9% |
| Q1 FY2025 | Mar 31, 2025 | -$1.27M | – |
| Q4 FY2024 | Dec 31, 2024 | -$21.45M | – |
| Q3 FY2024 | Sep 30, 2024 | -$8.79M | – |
| Q2 FY2024 | Jun 30, 2024 | $7.19M | – |
| Q1 FY2024 | Mar 31, 2024 | -$22.70M | – |
| Q4 FY2023 | Dec 31, 2023 | -$63.13M | – |
| Q3 FY2023 | Sep 30, 2023 | -$33.62M | – |
| Q2 FY2023 | Jun 30, 2023 | -$28.88M | – |
| Q1 FY2023 | Mar 31, 2023 | -$79.70M | – |
| Q4 FY2022 | Dec 31, 2022 | -$22.36M | – |
| Q3 FY2022 | Sep 30, 2022 | -$74.10M | – |
| Q2 FY2022 | Jun 30, 2022 | -$102.73M | – |
| Q1 FY2022 | Mar 31, 2022 | -$87.48M | – |
| Q4 FY2021 | Dec 31, 2021 | -$186.79M | – |
| Q3 FY2021 | Sep 30, 2021 | -$149.25M | – |
| Q2 FY2021 | Jun 30, 2021 | -$181.86M | -884.9% |
| Q1 FY2021 | Mar 31, 2021 | -$119.09M | – |
| Q4 FY2020 | Dec 31, 2020 | -$67.63M | – |
| Q3 FY2020 | Sep 30, 2020 | -$21.62M | – |
| Q2 FY2020 | Jun 30, 2020 | $23.17M | – |
| Q1 FY2020 | Mar 31, 2020 | -$26.63M | – |
See a number that looks wrong?